BACKGROUND: Antiretrovirals (ARVs) are recommended for maternal health and to reduce HIV-1 mother-to-child transmission, but suboptimal adherence can counteract its benefits. OBJECTIVES: To describe antepartum and postpartum adherence to ARV regimens and factors associated with adherence. METHODS: We assessed adherence rates among subjects enrolled in Pediatric AIDS Clinical Trials Group Protocol 1,025 from August 2002 to July 2005 on tablet formulations with at least one self-report adherence assessment. Perfectly adherent subjects reported no missed doses 4 days before their study visit. Generalized estimating equations were used to compare antepartum with postpartum adherence rates and to identify factors associated with perfect adherence. RESULTS: Of 519 eligible subjects, 334/445 (75%) reported perfect adherence during pregnancy. This rate significantly decreased 6, 24, and 48 weeks postpartum [185/284 (65%), 76/118 (64%), and 42/64 (66%), respectively (P < 0.01)]. Pregnant subjects with perfect adherence had lower viral loads. The odds of perfect adherence were significantly higher for women who initiated ARVs during pregnancy (P < 0.01), did not have AIDS (P = 0.02), never missed prenatal vitamins (P < 0.01), never used marijuana (P = 0.05), or felt happy all or most of the time (P < 0.01). CONCLUSIONS: Perfect adherence to ARVs was better antepartum, but overall rates were low. Interventions to improve adherence during pregnancy are needed.
BACKGROUND: Antiretrovirals (ARVs) are recommended for maternal health and to reduce HIV-1 mother-to-child transmission, but suboptimal adherence can counteract its benefits. OBJECTIVES: To describe antepartum and postpartum adherence to ARV regimens and factors associated with adherence. METHODS: We assessed adherence rates among subjects enrolled in Pediatric AIDS Clinical Trials Group Protocol 1,025 from August 2002 to July 2005 on tablet formulations with at least one self-report adherence assessment. Perfectly adherent subjects reported no missed doses 4 days before their study visit. Generalized estimating equations were used to compare antepartum with postpartum adherence rates and to identify factors associated with perfect adherence. RESULTS: Of 519 eligible subjects, 334/445 (75%) reported perfect adherence during pregnancy. This rate significantly decreased 6, 24, and 48 weeks postpartum [185/284 (65%), 76/118 (64%), and 42/64 (66%), respectively (P < 0.01)]. Pregnant subjects with perfect adherence had lower viral loads. The odds of perfect adherence were significantly higher for women who initiated ARVs during pregnancy (P < 0.01), did not have AIDS (P = 0.02), never missed prenatal vitamins (P < 0.01), never used marijuana (P = 0.05), or felt happy all or most of the time (P < 0.01). CONCLUSIONS: Perfect adherence to ARVs was better antepartum, but overall rates were low. Interventions to improve adherence during pregnancy are needed.
Authors: Loren G Miller; Honghu Liu; Ron D Hays; Carol E Golin; Zhishen Ye; C Keith Beck; Andrew H Kaplan; Neil S Wenger Journal: Clin Infect Dis Date: 2003-01-30 Impact factor: 9.079
Authors: Carol E Golin; Honghu Liu; Ron D Hays; Loren G Miller; C Keith Beck; Jeanette Ickovics; Andrew H Kaplan; Neil S Wenger Journal: J Gen Intern Med Date: 2002-10 Impact factor: 5.128
Authors: Jane Hitti; Lisa M Frenkel; Alice M Stek; Sharon A Nachman; David Baker; Adolfo Gonzalez-Garcia; Arthur Provisor; Edwin M Thorpe; Mary E Paul; Marc Foca; Jorge Gandia; Sharon Huang; Lee-Jen Wei; Laura M Stevens; D Heather Watts; James McNamara Journal: J Acquir Immune Defic Syndr Date: 2004-07-01 Impact factor: 3.731
Authors: Regis Kreitchmann; D Robert Harris; Fabiana Kakehasi; Jessica E Haberer; Pedro Cahn; Marcelo Losso; Elizabete Teles; Jose H Pilotto; Cristina B Hofer; Jennifer S Read Journal: AIDS Patient Care STDS Date: 2012-06-04 Impact factor: 5.078
Authors: Jane S Chen; Brian W Pence; Lisa Rahangdale; Kristine B Patterson; Claire E Farel; Amy L Durr; Amanda C Antono; Oksana Zakharova; Joseph J Eron; Sonia Napravnik Journal: AIDS Date: 2019-03-15 Impact factor: 4.177
Authors: Mary A Vogler; Laura M Smeaton; Rodney L Wright; Sandra W Cardoso; Jorge Sanchez; Rosa Infante; Laura E Moran; Catherine Godfrey; Lisa M Demeter; Victoria A Johnson Journal: J Acquir Immune Defic Syndr Date: 2014-04-15 Impact factor: 3.731
Authors: Nicole L Davis; William C Miller; Michael G Hudgens; Charles S Chasela; Dorothy Sichali; Dumbani Kayira; Julie A E Nelson; Jeffrey S A Stringer; Sascha R Ellington; Athena P Kourtis; Denise J Jamieson; Charles van der Horst Journal: AIDS Date: 2014-11-28 Impact factor: 4.177
Authors: Adriana Weinberg; Jeri E F Harwood; Elizabeth J McFarland; Jennifer Pappas; Jill Davies; Kay Kinzie; Emily Barr; Suzanne Paul; Carol Salbenblatt; Elizabeth Soda; Anna Vazquez; Charles A Peloquin; Myron J Levin Journal: Infect Dis Obstet Gynecol Date: 2010-01-10
Authors: Kristie E Appelgren; Paul J Nietert; Thomas C Hulsey; Bruce W Hollis; Carol L Wagner Journal: Int J Endocrinol Date: 2010-02-04 Impact factor: 3.257